Molecule
PrivateLast Round
Series B
Jul 16, 2025
Total Funding Raised
$24.97M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Molecule operates in Energy & Sustainability and is based in Houston, Texas. Its latest recorded funding round was a Series B round in July 2025.
Molecule is a software company that provides a cloud-native platform for Energy/Commodity Trading and Risk Management (ETRM/CTRM).
Sector
Energy & Sustainability
Verticals
Compliance & Risk, Financial Data, Renewable Energy, Vertical SaaS, Energy Management
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Molecule Comparables
Compare Molecule with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enuit | 87% | |
| Gen10 | 84% | |
| Previse Systems | 83% |
For institutional investors. Book with your work email.
Molecule Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 16, 2025 | ||||
| Series A | May 6, 2021 | ||||
| Seed | Nov 1, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Molecule Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Renewables.org | Series A |
| Sundance Growth | Series B |
| ENGIE New Ventures | Series A |
| Mercury Fund | Series A, Seed |
| Houston Angel Network | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 40% MoM, from 3.4K to 4.7K.
- Oct 16, 2025
Grew 16% QoQ, from 44 to 51 employees.
For institutional investors. Book with your work email.
Molecule Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Molecule's valuation, stock price, and market status.
Is Molecule a public or private company?
Molecule is a private company.
What is the current stock price of Molecule?
Molecule is a private company, so its shares have no public market price. Caplight tracks Molecule's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Molecule worth (valuation)?
Valuation information for Molecule is not publicly available.
Can I buy Molecule stock?
Molecule shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Molecule's last funding round?
Molecule's most recent funding round was Series B on July 16, 2025.
Who are the main investors in Molecule?
Key investors in Molecule include Sundance Growth, Mercury Fund.
Will Molecule IPO soon?
No public IPO plans have been announced for Molecule.
How can I track Molecule secondary market activity?
Caplight tracks bids, offers, and trades in Molecule's shares on secondary markets.